Clinical Trial Update: Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy

View source ↗

Summary

This clinical trial update investigates the incidence and risk factors of hydroxychloroquine- and chloroquine-associated retinopathy (toxic maculopathy).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Toxic Maculopathy

Drugs mentioned

• Aralen (chloroquine)
• Plaquenil (hydroxychloroquine)

Snippet

Sponsor: Asan Medical Center | Conditions: Toxic Maculopathy | Status: UNKNOWN